The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery
Ece Turan-Vural¹, Banu Torun-Acar¹, S Argun Kivanc², Suphi Acar¹¹Haydarpaşa Numune Education and Research Hospital, Ophthalmology Clinic, Istanbul, Turkey; ²Umranıye Education and Research Hospital, Ophthalmology Clinic, I...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-06-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/the-effect-of-topical-005-cyclosporine-on-recurrence-following-pterygi-a7756 |
id |
doaj-ec46a63564cd478c863f6f4736f5b407 |
---|---|
record_format |
Article |
spelling |
doaj-ec46a63564cd478c863f6f4736f5b4072020-11-24T21:42:08ZengDove Medical PressClinical Ophthalmology1177-54671177-54832011-06-012011default881885The effect of topical 0.05% cyclosporine on recurrence following pterygium surgeryTuran-Vural ETorun-Acar BTKivanc SAAcar SEce Turan-Vural¹, Banu Torun-Acar¹, S Argun Kivanc², Suphi Acar¹¹Haydarpaşa Numune Education and Research Hospital, Ophthalmology Clinic, Istanbul, Turkey; ²Umranıye Education and Research Hospital, Ophthalmology Clinic, Istanbul, TurkeyPurpose: To investigate the role of postoperative topical 0.05% cyclosporine A (CsA) eye drops (Restasis®, Allergan Pharmaceutical) in the prevention of recurrence among patients with primary pterygium treated with bare-sclera technique.Methods: In this prospective randomized controlled study, 36 eyes (34 patients) with primary pterygium were randomized into two groups: Group I comprised 18 eyes (18 patients), and Group II comprised 18 eyes (16 patients). Bare sclera technique was performed in both groups. In Group I, 0.05% CsA was administered postoperatively at 6-hour intervals for 6 months, and Group II did not receive any cyclosporine treatment. The patients were assessed for recurrence, side effects, and complications at postoperative 1 and 7 days as well as each month during the following year. Conjunctival advances which showed a limbus higher than 1 mm were recognized as recurrence.Results: Recurrence occurred in four patients (22.2%) in Group I and in eight (44.4%) patients in Group II.Conclusion: Postoperative application of low-dose CsA can be effective for preventing recurrences after primary pterygium surgery.Keywords: primary pterygium, cyclosporine A, bare sclerahttp://www.dovepress.com/the-effect-of-topical-005-cyclosporine-on-recurrence-following-pterygi-a7756 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Turan-Vural E Torun-Acar BT Kivanc SA Acar S |
spellingShingle |
Turan-Vural E Torun-Acar BT Kivanc SA Acar S The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery Clinical Ophthalmology |
author_facet |
Turan-Vural E Torun-Acar BT Kivanc SA Acar S |
author_sort |
Turan-Vural E |
title |
The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery |
title_short |
The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery |
title_full |
The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery |
title_fullStr |
The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery |
title_full_unstemmed |
The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery |
title_sort |
effect of topical 0.05% cyclosporine on recurrence following pterygium surgery |
publisher |
Dove Medical Press |
series |
Clinical Ophthalmology |
issn |
1177-5467 1177-5483 |
publishDate |
2011-06-01 |
description |
Ece Turan-Vural¹, Banu Torun-Acar¹, S Argun Kivanc², Suphi Acar¹¹Haydarpaşa Numune Education and Research Hospital, Ophthalmology Clinic, Istanbul, Turkey; ²Umranıye Education and Research Hospital, Ophthalmology Clinic, Istanbul, TurkeyPurpose: To investigate the role of postoperative topical 0.05% cyclosporine A (CsA) eye drops (Restasis®, Allergan Pharmaceutical) in the prevention of recurrence among patients with primary pterygium treated with bare-sclera technique.Methods: In this prospective randomized controlled study, 36 eyes (34 patients) with primary pterygium were randomized into two groups: Group I comprised 18 eyes (18 patients), and Group II comprised 18 eyes (16 patients). Bare sclera technique was performed in both groups. In Group I, 0.05% CsA was administered postoperatively at 6-hour intervals for 6 months, and Group II did not receive any cyclosporine treatment. The patients were assessed for recurrence, side effects, and complications at postoperative 1 and 7 days as well as each month during the following year. Conjunctival advances which showed a limbus higher than 1 mm were recognized as recurrence.Results: Recurrence occurred in four patients (22.2%) in Group I and in eight (44.4%) patients in Group II.Conclusion: Postoperative application of low-dose CsA can be effective for preventing recurrences after primary pterygium surgery.Keywords: primary pterygium, cyclosporine A, bare sclera |
url |
http://www.dovepress.com/the-effect-of-topical-005-cyclosporine-on-recurrence-following-pterygi-a7756 |
work_keys_str_mv |
AT turanvurale theeffectoftopical005cyclosporineonrecurrencefollowingpterygiumsurgery AT torunacarbt theeffectoftopical005cyclosporineonrecurrencefollowingpterygiumsurgery AT kivancsa theeffectoftopical005cyclosporineonrecurrencefollowingpterygiumsurgery AT acars theeffectoftopical005cyclosporineonrecurrencefollowingpterygiumsurgery AT turanvurale effectoftopical005cyclosporineonrecurrencefollowingpterygiumsurgery AT torunacarbt effectoftopical005cyclosporineonrecurrencefollowingpterygiumsurgery AT kivancsa effectoftopical005cyclosporineonrecurrencefollowingpterygiumsurgery AT acars effectoftopical005cyclosporineonrecurrencefollowingpterygiumsurgery |
_version_ |
1716664173649199104 |